Arrangement - Side 5

SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.

Dr. Ville Mustonen, Professor at the Department of Computer Science and Institute of Biotechnology, University of Helsinki and the Helsinki Institute for Information Technology, Finland, will present the lecture "Using computational methods and evolutionary theory to combat drug resistance."

Dr. Evangelia Petsalaki, Group Leader at EMBL-EBI, will present the lecture entitled "Integrative studies of context-specific signalling."

SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.

Dr. Florian Markowetz, Group Leader of the Integrative Cancer Biology team at the Cancer Research UK Cambridge Institute, Cambridge, UK, will present his current research.

SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.

Having a new idea is not enough to create a new innovation. The hardest part is to build a successful business around it – this is the entrepreneurial challenge. One of the key elements that needs to be worked out is the right Go-To-Market strategy.

Dr. Matti Nykter, Professor at the Tampere University, Finland, will present the lecture "Computational analysis to understand aberrant gene expression and treatment induced responses in prostate cancer."

To develop your idea into a growing business you need an excellent and well-functioning team. Learn more about what it takes to build a team and establish and grow a successful business and use the opportunity to discuss with an experienced industry expert during this interactive seminar.

Dr. Colm Ryan, Assistant Professor at the University College Dublin, will present the lecture "Identifying robust genetic interactions in cancer."

Forming a business partnership can be beneficial or even vital to obtain success, but it has to be done correctly. If not, it can be catastrophic. Learn more about what it takes to secure a successful partnering and finance setup. What are the pitfalls? What is critical? What are the dos and don'ts?

Procedures that work in the lab don’t always scale-up seamlessly into production in the life science industry. Process development while staying compliant will be required. What should be considered when you work in lab-scale to make the transition to production smoother? What are the common pitfalls, and what are the dos and don’ts?

Dr. Tero Aittokallio, Professor at the Oslo Centre for Biostatistics and Epidemiology and Group Leader at the Institute for Cancer Research, Oslo, Norway, will present his lecture "Predictive modelling of drug combination effects for precision medicine."

Vi feirer 50-årsdagen for Odd Hassels Nobelpris i kjemi: Program og påmelding til Hassel-seminaret 31. oktober til og med 1. november. 

This symposium brings together world leaders in the ER proteostasis field in Oslo to showcase new research in this burgeoning field and its links to different aspects of normal cellular function as well as disease states, and aims stimulate new collaborative research.

Repurposing of drugs can potentially bring medications with known safety profiles to new patient groups. What is the industry looking for when they consider to invest in a repurposing project? What is the regulatory framework in this area? How is IP handled?

We are pleased to announce that Dr. Adam Novak will be the guest speaker of our upcoming Sven Furberg Seminar in Bioinformatics and Statistical Genomics on the coming Friday, Sep 27, at 14:30 in Lille auditorium, Kristen Nygaards hus.

Dr. Adam Novak, senior software engineer in the UCSC Genomics Institute, will present his lecture "Graph-based genome representations".

Abstract:

Graph-based approaches to genomics problems can beat out traditional linear-reference-based tools, reducing reference allele bias and improving structural variant calling. For these reasons and others, graph genomics techniques are becoming more popular, and more graph-based tools are being developed. Here I present lessons on genome graph API design learned during the development of the vg variation graph toolkit. I show how techniques and libraries extracted from vg can be used to help developers quickly bootstrap new graph-based projects, forming an ecosystem of interoperable graph genomics tools.

UiO satser stort på livsvitenskap og ønsker å bidra til ny helsenæring. Thermo Fisher Scientific er ett av firmaene som har lykkes med å ta norske forskningsresultater videre til anvendelse over hele verden, samtidig som de har bevart aktivitet i Norge. Hva ser de etter hos studenter fra UiO, og hva kan de tilby? Møt også en ung forsker fra UiO:Livsvitenskaps innovasjonsprogram SPARK Norway.

Skal universitetet spille en rolle i å løse klimakrisen? Hvilken effekt har skolestreikene? Må professorer fly, og hvordan skal vi utdanne fremtidige studenter til et bærekraftig arbeidsliv? Vi tar debattene på Kulturhuset.

Hvorfor er medisinske forskere opptatt av torsken? Har du hørt lyden av torsk? Test dine kunnskaper i den store torskequizen og vinn fine premier.

Hva skulle vi gjort uten havet? Bli med på en bevisstgjørende frokost med forskere fra UiO og kunstnere. Vi dypdykker ned i det mørke, store blå og får myter knust og fakta formidlet.

A part of Nordic Life Science Awards that features exciting academic projects from five Nordic countries illustrating the rich and broad research milieus and their motivation to advance their ideas into innovations for patients.

Clinical trials are essential to develop new treatments. What are the fundamental issues that must be considered when designing clinical trials? What are the pitfalls? What are the dos and don’ts?

The UiO:Life Science ImmunoLingo Convergence Environment Symposium.